Stereotactic surgery devices market seen growing to $30.94 billion by 2030

The Business Research Company says the stereotactic surgery devices market will rise from $23.84 billion in 2026 to $30.94 billion by 2030, supported by demand for precision neurosurgery, AI-assisted planning and minimally invasive care. North America led the market in 2025, while aging populations and neurological disease rates are expected to keep pushing adoption.

Why it matters: - Stereotactic surgery devices are used for highly precise, minimally invasive brain procedures. - Market growth points to stronger demand for precision neurosurgery, radiosurgery platforms and image-guided treatment tools. - Rising rates of neurological disease and an aging population are expanding the pool of patients who may need these procedures.

What happened: - The Business Research Company released a stereotactic surgery devices market report covering 2026 to 2035. - The market is projected to grow from $22.44 billion in 2025 to $23.84 billion in 2026. - The report forecasts the market will reach $30.94 billion by 2030. - The forecast implies a 6.2% CAGR from 2025 to 2026 and a 6.7% CAGR through 2030. - North America was the largest regional market in 2025. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - A free sample of the report is available here. - The full report is available here.

The details: - The market’s recent growth has been driven by a higher prevalence of neurological disorders. - Expansion of neurosurgical centers has also supported demand. - Wider use of gamma knife systems has added momentum. - Adoption of minimally invasive brain procedures and advances in medical imaging have helped the market grow. - Future growth is expected to come from higher demand for precision neurosurgery. - Investment in advanced radiosurgery platforms is another growth driver. - AI integration in surgical planning is expected to shape the market. - Growing acceptance of non-invasive treatments is also part of the outlook. - The report highlights image-guided stereotactic systems, robotic-assisted neurosurgery and high-precision navigation technologies as key trends. - The report also points to a stronger focus on treatment accuracy and safety. - Stereotactic surgical devices use a three-dimensional coordinate system to locate specific brain regions while the patient’s head remains fixed. - The devices can support implantation of medications or hormones directly into the brain during stereotactic surgery. - Parkinson’s disease and epilepsy are major demand drivers for the market. - Parkinson’s disease is a neurodegenerative disorder marked by tremors, slow movement and muscle stiffness. - Epilepsy is a neurological condition marked by recurrent, unprovoked seizures. - These devices are also used in treating movement, pain and psychiatric conditions. - In November 2024, the British Psychological Society reported that about 100,000 people in Wales live with long-term neurological disorders. - The same report said more than 41,000 people in Wales are affected by Parkinson’s disease, epilepsy, multiple sclerosis, muscular dystrophy, motor neurone disease or cerebral palsy. - The British Psychological Society also said about 2,500 new cases of Parkinson’s disease, epilepsy, multiple sclerosis or motor neurone disease are diagnosed each year in Wales. - The World Health Organization said in October 2025 that by 2030, one in six people globally will be aged 60 or older. - The World Health Organization projected the 60-plus population will double to 2.1 billion by 2050.

Between the lines: - The market outlook suggests hospitals and device makers are shifting toward less invasive procedures that still require high placement accuracy. - AI and robotic assistance are becoming more important because the market is being shaped by precision, safety and workflow efficiency. - North America’s lead in 2025 suggests the region has the strongest current adoption base, while global aging trends point to longer-term demand in more markets.

What's next: - The report expects expansion to continue through 2030 as neurological disease burden and elderly care needs rise. - Further adoption of image-guided and robotic-assisted systems will likely define the next phase of market growth. - The Business Research Company said its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspot infographics and updated graphics and tables.

The bottom line: - Stereotactic surgery devices are moving from a niche neurosurgical toolset toward a broader precision-care market, with growth anchored by aging populations, neurological disease and technology upgrades.